This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast

By PVI, PeerView Institute for Medical Education

PeerView is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

  1. 1.
    Jay B. Wish, MD / Daniel W. Coyne, MD / Chilnille L. Milbrooks, MSN, FNP-C - Evolving Management Approaches to Anemia in Chronic Kidney Disease: Implications for the Nephrology Nurse11/11/2020
    1:15:13
  2. 2.
    Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN - Visualizing the Potential Role of HIF-PH Inhibitors in the Treatment of Anemia in Chronic Kidney Disease11/06/2020
    20:08
  3. 3.
    Kenneth C. Kalunian, MD / Maureen A. McMahon, MD / Joan T. Merrill, MD - Candid Conversations in Lupus: Navigating Advances in Diagnosis and Treatment to Provide Optimal Care for Each Patient10/26/2020
    1:11:31
  4. 4.
    John B. Buse, MD, PhD - Complex Cases in Contemporary Practice: Applying New Evidence for SGLT2 Inhibitors in the Management of Patients With Comorbid Cardiometabolic Diseases09/18/2020
    1:16:25
  5. 5.
    George D. Demetri, MD - Modern Diagnostics and Targeted Therapy for TRK Fusion Cancers: Pathology-Oncologist Collaboration in the Era of Precision Medicine09/11/2020
    1:11:16
  6. 6.
    Georgine Lamvu, MD, MPH - Current and Emerging Therapies for Endometriosis and Uterine Fibroids: What Do You Need to Know?09/08/2020
    38:12
  7. 7.
    Javed Butler, MD, MPH, MBA - Strategies for Increasing Recognition and Diagnosis of Patients With Heart Failure: Evaluating the Role of Natriuretic Peptides As Clinical Biomarkers09/07/2020
    52:02
  8. 8.
    Arjun Balar, MD - Evidence and Insights on Innovative Treatment for Bladder Cancer: Clinical Breakthroughs From Targeted and Immune Options to Antibodies and Gene Therapy09/04/2020
    1:09:38
  1. 9.
    "Bradley J. Monk, MD, FACS, FACOG - Optimizing Precision Medicine in Ovarian Cancer: Expert Insights on Clinical Implications of PARP Inhibitor Therapy and Companion Diagnostics"09/02/2020
    1:03:32
  2. 10.
    Emmanuel S. Antonarakis, MD - Targeting DNA Repair Defects Through PARP Inhibition in Prostate Cancer: Rationale, Evidence, and Clinical Implications08/28/2020
    44:17
  3. 11.
    William K. Oh, MD - How I Think, How I Treat: Learning to Navigate the Modern Prostate Cancer Landscape08/10/2020
    1:05:43
  4. 12.
    Arjun Balar, MD - Innovative Treatments for Bladder Cancer: Thoughts From the Chair07/27/2020
    25:30
  5. 13.
    Vanita R. Aroda, MD - Test Your Knowledge: Current Guidance on GLP-1 Receptor Agonists to Individualize Treatment for T2DM07/24/2020
    33:12
  6. 14.
    William K. Oh, MD - Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence07/17/2020
    36:30
  7. 15.
    Bradley J. Monk, MD, FACS, FACOG - Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management07/08/2020
    28:21
  8. 16.
    Finding the Path to Clinically Meaningful Outcomes Among Expanding Treatment Options in Renal Cell Carcinoma06/24/2020
    1:39:06
  9. 17.
    Robin Lachmann, MD, PhD / Melissa Wasserstein, MD - Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency06/12/2020
    1:02:52
  10. 18.
    Bradley J. Monk, MD, FACS, FACOG - Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer05/15/2020
    34:41
  11. 19.
    William K. Oh, MD - Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook05/01/2020
    1:25:53
  12. 20.
    Arjun Balar, MD - Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options04/08/2020
    1:14:35
  13. 21.
    Arjun Balar, MD - Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care03/27/2020
    1:16:04
  14. 22.
    Toni K. Choueiri, MD - How I Think, How I Treat: Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC02/19/2020
    37:55
  15. 23.
    Robert Coleman, MD - Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors02/10/2020
    1:16:51
  16. 24.
    Jay B. Wish, MD - Exploring Emerging Strategies in the Management of Anemia in Chronic Kidney Disease01/24/2020
    1:12:04
  17. 25.
    Mikhail Kosiborod, MD, FACC, FAHA - Reducing Cardiovascular Risks in Patients With Type 2 Diabetes: Identifying Your Role on the Diabetes Management Team01/10/2020
    1:18:01
  18. 26.
    Matthew R. Weir, MD - Addressing the Disease Burden Associated With Anemia of Chronic Kidney Disease: Expert Insight on the Clinical Potential of HIF-PH Inhibitors01/08/2020
    41:27
  19. 27.
    Javed Butler, MD, MPH, MBA - Early Recognition and Management of Chronic Heart Failure in the Primary Care Setting12/18/2019
    43:11
  20. 28.
    Julia Batten, APRN, MSN, MPH - Virginia J. Seery, MSN, RN, ANP-BC - The Urologic Nurse Meets the Challenge of Renal Cell Carcinoma: Insights on Patient Care in an Expanding Treatment Landscape10/23/2019
    49:27
  21. 29.
    James R. Gavin III, MD, PhD - Swimming in Cloudy Water: Using the Latest Guidelines to Clear Up Clinical Confusion About T2DM Management09/04/2019
    1:12:48
  22. 30.
    Robert Dreicer, MD, MS, MACP, FASCO - New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes07/29/2019
    1:24:34
  23. 31.
    David F. McDermott, MD - Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy07/26/2019
    1:07:31
  24. 32.
    Elizabeth A. Stewart, MD - Advances in Medical Options for Uterine Fibroids and Endometriosis: Clinical Highlights From Montreal07/15/2019
    30:09
  25. 33.
    Evan J. Lipson, MD - Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies07/10/2019
    33:08
  26. 34.
    John B. Buse, MD, PhD - An Update on SGLT2 Inhibition for the Prevention and Treatment of Kidney Disease in Patients With Type 2 Diabetes07/05/2019
    40:19
  27. 35.
    Adrian Hernandez, MD, MHS - Recognizing and Treating Iron Deficiency in Patients With Heart Failure: Achieving Better Outcomes and Quality of Life07/01/2019
    17:40
  28. 36.
    Jay B. Wish, MD - Addressing Unmet Needs in Managing Anemia in Chronic Kidney Disease: A Closer Look at the Clinical Potential of HIF-PH Inhibitors06/21/2019
    27:43
  29. 37.
    Neal D. Shore, MD, FACS - Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care06/19/2019
    1:08:58
  30. 38.
    Javed Butler, MD, MPH, MBA - New Frontiers in Managing Heart Failure: Are SGLT2 Inhibitors the Next Leap Forward in Optimizing Patient Care?06/10/2019
    31:46
  31. 39.
    Kimberly Halla, MSN, FNP-C - Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Oncology Nurses on the Advances and Challenges06/05/2019
    1:08:09
  32. 40.
    John E. Anderson, MD - Realizing Your Patient’s Potential: Embracing the Guidelines to Appropriately Individualize Care for Patients With Type 2 Diabetes05/06/2019
    32:44
  33. 41.
    Robert Dreicer, MD, MS, MACP, FASCO - Unraveling the Complexities of Prostate Cancer Management: Focus on Therapeutic Decisions for Early-Stage Disease and the Implications for Later-Stage Disease03/29/2019
    1:09:03
  34. 42.
    David F. McDermott, MD - Making Effective Therapeutic Choices for Advanced RCC in an Evolving Treatment Landscape: Personal Insights From the Patient CaseBook03/27/2019
    1:09:12
  35. 43.
    Anna F. Farago, MD, PhD - The TRK to Tumor-Agnostic Care in Solid Tumors: A Pathology-Focused Guide to the Clinical Role of TRK Fusions in Personalizing Cancer Therapy03/06/2019
    38:56
  36. 44.
    Arjun Balar, MD - Keeping Pace With Immunotherapy Advances in Bladder Cancer: Tools for Winning the Race and Optimizing Patient Outcomes02/19/2019
    1:16:59

Listen to PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast now.

Listen to PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Audio Podcast in full in the Spotify app